Hearing Loss Trial, Recruiting (NCT07294976)

Hearing Loss Trial, Recruiting NCT07294976 Sponsor: Oticon Medical Condition: Hearing Loss

Printed from Voxsanity (voxsanity.com.au) — NCT07294976 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hearing Loss

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You currently use a bone-anchored hearing system (BAHS) with a specific type of attachment (abutment) that is compatible with Oticon Medical devices
You have signed a form agreeing to take part in the study
You are 18 years of age or older
You have a specific type of hearing loss in one ear, where hearing through bone conduction falls within a certain range (confirm with trial site for exact details)
The difference between how well you hear through bone versus through air in that ear meets a specific minimum level (confirm with trial site for exact details)
You have been using a bone conduction hearing device for at least 3 months
You are fluent in Swedish and can read and understand the study information and consent documents

Who may not be able to join:

You are currently taking part in another clinical study that could interfere with this one
You are unable or unwilling to follow the study's requirements, such as filling out questionnaires, as judged by the study team

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +46 (0)70 098 17 15

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07294976

Sponsor: Oticon Medical

Phase: Not Applicable

Status: Recruiting

Condition: Hearing Loss

Trial contact: +46 (0)70 098 17 15

More information: https://clinicaltrials.gov/study/NCT07294976

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You currently use a bone-anchored hearing system (BAHS) with a specific type of attachment (abutment) that is compatible with Oticon Medical devices
You have signed a form agreeing to take part in the study
You are 18 years of age or older
You have a specific type of hearing loss in one ear, where hearing through bone conduction falls within a certain range (confirm with trial site for exact details)
The difference between how well you hear through bone versus through air in that ear meets a specific minimum level (confirm with trial site for exact details)
You have been using a bone conduction hearing device for at least 3 months
You are fluent in Swedish and can read and understand the study information and consent documents

Who may not be able to join:

You are currently taking part in another clinical study that could interfere with this one
You are unable or unwilling to follow the study's requirements, such as filling out questionnaires, as judged by the study team

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Oticon Medical

Registry

ClinicalTrials.gov

Start date

4 December 2025

Est. completion

15 January 2026

Where this trial is recruiting

🇸🇪 Sweden

Primary endpoints

Difference in actual maximum gain in dB, between Device A compared to Device B for the mean average of the frequencies 500, 1000, 2000, 3000 and 4000

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov